Chandra Bhagat Pharma Ltd Financials
Company Logo

Chandra Bhagat Pharma Ltd Financial Statement

Chandra Bhagat Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Chandra Bhagat Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual221.37
Operating Expenses Annual228.41
Operating Profit Annual4.29
Interest Annual1.39
Depreciation0.49
Net Profit Annual1.53
Tax Annual0.73

Chandra Bhagat Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning6.44
Cash Flow from Operations6.18
Cash Flow from Investing-1.85
Cash Flow from Financing-5.80
Cash Flow at the End4.96

Chandra Bhagat Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)1.94
PBIT Margin (%)1.65
PBT Margin (%)0.46
Net PROFIT Margin (%)0.69
Return On Networth / Equity (%)5.42
Return On Networth /Employed (%)7.73
Return On Assets (%)3.24
Total Debt / Equity (X)0.63
Asset Turnover Ratio (%)4.69

Chandra Bhagat Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual2.52
Total Current Assets Annual97.92
Non Current Assets Annual3.89
Total Shareholders Funds Annual29.01
Total Assets Annual101.80

Chandra Bhagat Pharma Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Chandra Bhagat Pharma Ltd has a market capitalization of 71.68 Cr. Value Research classifies it as a Micro-Cap company.
No, Chandra Bhagat Pharma Ltd is not debt-free with a debt-to-equity ratio of 0.57.
In FY 2023 , Chandra Bhagat Pharma Ltd recorded a total revenue of approximately 221.37 Cr marking a significant milestone in the company's financial performance.
Chandra Bhagat Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.4% annually, respectively..
Chandra Bhagat Pharma Ltd's current PE ratio is 46.85.
Chandra Bhagat Pharma Ltd's ROCE averaged 7.7% from the FY ending March 2022 to 2024, with a median of 8.0%. It peaked at 8.3% in March 2022, reflecting strong capital efficiency over the period..
Chandra Bhagat Pharma Ltd's latest EBIT is Rs. 3.65 Cr, surpassing the average EBIT of Rs. 3.73 Cr over the 5 years..